At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 60 enrolled
Drug / intervention
Rabies vaccine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Immunogenicity of a Two vs Three Dose, Intradermal (ID) vs Intramuscular (IM) Administration of a Licensed Rabies Vaccine for Pre-Exposure Vaccination
State University of New York - Upstate Medical University·interventional·Posted Mar 2, 2015·Updated Jun 13, 2022
In Brief
A Phase 4 clinical trial evaluating Rabies vaccine and Placebo for Rabies. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the effectiveness of a two dose versus a three dose schedule and intramuscular versus intradermal injection for pre-exposure prophylaxis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRabies
CountriesUnited States
CollaboratorsWalter Reed Army Institute of Research (WRAIR)
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 2015
Enrollment StartMar 2015
Primary CompletionSep 2016
TodayJul 2026
First PostedMar 2, 2015
Enrollment StartMar 24, 2015
Primary CompletionSep 22, 2016
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 11.3 years ago
Interventions
Rabies vaccinedrug
Compare dose schedule and route of administration
Placebodrug
Placebo